Clinical trial
Open-Label Duloxetine Extension Phase in Patients Who Have Completed the HMDG Clinical Trial
NCT00191594 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-Label Duloxetine Extension Phase in Patients Who Have Completed the HMDG Clinical Trial
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- August 31, 2006
- Enrollment
- 105
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.